Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Feb 10 2022;43(6):474-484
Among them, PLGAOltipraz nanoparticles (100 nm) enable targeted delivery of the Nrf2 activator Oltipraz to renal tubular epithelial cells by penetrating the damaged glomerular filtration barrier
In preclinical models of glaucoma, neuroprotection appears to be strongly linked to the anti-inflammatory properties of GLP-1RAs
doi: 10.1016/j.jep.2023.117089 96 ChyauC-CWangH-FZhangW-JChenC-CHuangS-HChangC-Cet al
Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects
US$ 29.02
US$ 20.75
US$ 27.54
US$ 26.97
US$ 21.88
US$ 22.41
US$ 22.96
US$ 21.11
